Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer

NCT00382070 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00382070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Lead sponsor
NSABP Foundation Inc
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2006
Completion date
April 30, 2025
Enrollment
3,966 (actual)
Sites
806

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer